Basic and clinical studies have revealed that IL-5 is essential for the development of BHR, at least in Th2 cell-mediated asthma, by reducing allergen-induced airway eosinophilic inflammation via its neutralizing antibody [29,30,31]. This evidence concerns the gene IL5 and asthma.